Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,414 shares at $152.94 ($369K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Scheduled sale ($369k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.94 | 1,207 | $185K | 50.0% |
| 2 | $152.94 | 1,207 | $185K | 50.0% |
| Total | $152.94 avg | 2,414 | $369K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2024-04-17 | $5.3M | — | Filing → |